BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21518756)

  • 1. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
    Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
    J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.
    Kai HS; Butler GS; Morrison CJ; King AE; Pelman GR; Overall CM
    J Biol Chem; 2002 Dec; 277(50):48696-707. PubMed ID: 12374789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
    Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
    Batra J; Soares AS; Mehner C; Radisky ES
    PLoS One; 2013; 8(9):e75836. PubMed ID: 24073280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
    Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis.
    Aplin AC; Zhu WH; Fogel E; Nicosia RF
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C471-80. PubMed ID: 19494241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.
    Remacle AG; Golubkov VS; Shiryaev SA; Dahl R; Stebbins JL; Chernov AV; Cheltsov AV; Pellecchia M; Strongin AY
    Cancer Res; 2012 May; 72(9):2339-49. PubMed ID: 22406620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display.
    Hosseini A; Kumar S; Hedin K; Raeeszadeh-Sarmazdeh M
    Protein Sci; 2023 Dec; 32(12):e4795. PubMed ID: 37807423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
    Wei S; Xie Z; Filenova E; Brew K
    Biochemistry; 2003 Oct; 42(42):12200-7. PubMed ID: 14567681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).
    Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR
    J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H; Brew K
    Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
    Xu X; Mikhailova M; Chen Z; Pal S; Robichaud TK; Lafer EM; Baber S; Steffensen B
    Matrix Biol; 2011 Sep; 30(7-8):404-12. PubMed ID: 21839835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of matrix metalloproteinases and their inhibitors in primordial germ cell migration.
    Díez-Torre A; Díaz-Núñez M; Eguizábal C; Silván U; Aréchaga J
    Andrology; 2013 Sep; 1(5):779-86. PubMed ID: 23843195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).
    Vallon R; Müller R; Moosmayer D; Gerlach E; Angel P
    Eur J Biochem; 1997 Feb; 244(1):81-8. PubMed ID: 9063449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
    Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
    J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.